Despite the promising biological and antioxidant properties of curcumin, its medical applications are limited due to poor solubility in water and low bioavailability. Polymeric nanoparticles (NPs) adapted to oral delivery may overcome these drawbacks. Properties such as particle size, zeta potential, morphology and encapsulation efficiency were assessed. Then, the possibility of storing these NPs in a solid-state form obtained by freeze-drying, in vitro curcumin dissolution and cytocompatibility towards intestinal cells were evaluated. Curcumin-loaded Eudragit® RLPO (ERL) NPs showed smaller particle diameters (245 ± 2 nm) and better redispersibility after freeze-drying than either poly(lactic-co-glycolic acid) (PLGA) or polycaprolactone (PCL) NPs. The former NPs showed lower curcumin encapsulation efficiency (62%) than either PLGA or PCL NPs (90% and 99%, respectively). Nevertheless, ERL NPs showed rapid curcumin release with 91 ± 5% released over 1 h. The three curcumin-loaded NPs proposed in this work were also compatible with intestinal cells. Overall, ERL NPs are the most promising vehicles for increasing the oral bioavailability of curcumin.
To
date, a large number of active molecules are hydrophilic and
aromatic low molecular-weight drugs (HALMD). Unfortunately, the
low capacity of these molecules to interact with excipients and the
fast release when a formulation containing them is exposed to biological
media jeopardize the elaboration of drug delivery systems by using
noncovalent interactions. In this work, a new, green, and highly efficient
methodology to noncovalently attach HALMD to hydrophilic aromatic
polymers to create nanocarriers is presented. The proposed method
is simple and consists in mixing an aqueous solution containing HALMD
(model drugs: imipramine, amitriptyline, or cyclobenzaprine) with
another aqueous solution containing the aromatic polymer [model polymer:
poly(sodium 4-styrenesulfonate) (PSS)]. NMR experiments demonstrate
strong chemical shifting of HALMD aromatic rings when interacting
with PSS, evidencing aromatic–aromatic interactions. Ion pair
formation and aggregation produce the collapse of the system in the
form of nanoparticles. The obtained nanocarriers are spheroidal, their
size ranging between 120 and 170 nm, and possess low polydispersity
(≤0.2) and negative zeta potential (from −60 to −80
mV); conversely, the absence of the aromatic group in the polymer
does not allow the formation of nanostructures. Importantly, in addition
to high drug association efficiencies (≥90%), the formed nanocarriers
show drug loading values never evidenced for other systems comprising
HALMD, reaching ≈50%. Diafiltration and stopped flow experiments
evidenced kinetic drug entrapment governed by molecular rearrangements.
Importantly, the nanocarriers are stable in suspension for at least
18 days and are also stable when exposed to different high ionic strength,
pH, and temperature values. Finally, they are transformable to a reconstitutable
dry powder without losing their original characteristics. Considering
the large quantity of HALMD with importance in therapeutics and the
simplicity of the presented strategy, we envisage these results as
the basis to elaborate a number of drug delivery systems with applications
in different pathologies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.